Matthew Szot
Overview
Matthew Szot received an average of $602K in total compensation, including $189K in salary, at Cadrenal Therapeutics between 2022 and 2023.
Source: SEC filing on June 11, 2024.
Related executives
We found two more executives who work or worked at Cadrenal Therapeutics.